| DB ID | MyCo_1328 |
| Title | Diagnostic surveillance by Candida albicans germ tube antibody in intensive care unit patients |
| Year | 2019 |
| PMID | 30902614 |
| Fungal Diseases involved | Invasive candidiasis |
| Associated Medical Condition | None |
| Genus | Candida |
| Species | albicans |
| Organism | Candida albicans |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | CAGTA |
| Biomarker Full Name | Candida albicans germ tube antibody |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Italy |
| Cohort | A retrospective observational study was conducted at the University hospitals “Policlinico-Vittorio Emanuele”, Cata-nia, Italy, over a 1-year period (January 2015eDecember 2015) in the medical, surgical and respiratory ICU setting in routine clinical practice. Seventy critically ill patients were included in the study and a total of 361 serum samples (mean 5.1 per patient, range 2e20) were collected for the CAGTA detection assay. |
| Cohort No. | 70 |
| Age Group | 19-91 |
| P Value | None |
| Sensitivity | 0.913 |
| Specificity | 0.681 |
| Positive Predictive Value | 0.583 |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Immunological assay |
| Analysis Method | CAGTA detection assay |
| ELISA kits | None |
| Assay Data | CAGTA detection assay (C. albicans immunofluorescence assay immunoglobulin G; Vircell, Spain) |
| Validation Techniques used | CAGTA detection assay |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
